PMC:7405836 / 113185-117879
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T31 | 21-29 | Body_part | denotes | Antibody | http://purl.org/sig/ont/fma/fma62871 |
| T32 | 285-292 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T33 | 466-473 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T34 | 801-808 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T35 | 1067-1077 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
| T36 | 1142-1152 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
| T37 | 2094-2101 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T38 | 2809-2814 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T39 | 2918-2924 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T40 | 3262-3276 | Body_part | denotes | cell membranes | http://purl.org/sig/ont/fma/fma63841 |
| T41 | 3262-3266 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T42 | 3370-3378 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T43 | 3546-3554 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T44 | 3612-3620 | Body_part | denotes | cysteine | http://purl.org/sig/ont/fma/fma82751 |
| T45 | 4003-4009 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T46 | 4103-4109 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T47 | 4150-4155 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T48 | 4157-4165 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T49 | 4209-4217 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T50 | 4304-4310 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T51 | 4538-4544 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T129 | 2809-2814 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
| T130 | 4150-4155 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T994 | 170-174 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T995 | 230-239 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T996 | 846-854 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T997 | 846-850 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T998 | 956-964 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T999 | 956-960 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1000 | 1095-1103 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1001 | 1095-1099 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1002 | 1254-1262 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1003 | 1254-1258 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1004 | 1276-1284 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1005 | 1276-1280 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1006 | 1309-1317 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1007 | 1309-1313 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1008 | 1386-1394 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T1009 | 1542-1550 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T1010 | 1594-1602 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1011 | 1594-1598 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1012 | 1606-1614 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T1013 | 1686-1694 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T1014 | 1707-1715 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1015 | 1707-1711 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1016 | 1764-1772 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1017 | 1764-1768 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1018 | 1849-1857 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T1019 | 1979-1987 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T1020 | 2008-2016 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1021 | 2008-2012 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1022 | 2105-2113 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1023 | 2105-2109 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1024 | 2199-2207 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1025 | 2199-2203 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1026 | 2212-2220 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1027 | 2212-2216 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1028 | 2422-2430 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T1029 | 2975-2983 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T1030 | 3421-3430 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T1031 | 3438-3449 | Disease | denotes | hepatitis C | http://purl.obolibrary.org/obo/MONDO_0005231 |
| T1032 | 3438-3447 | Disease | denotes | hepatitis | http://purl.obolibrary.org/obo/MONDO_0002251 |
| T1033 | 3457-3462 | Disease | denotes | Ebola | http://purl.obolibrary.org/obo/MONDO_0005737 |
| T1034 | 3474-3480 | Disease | denotes | dengue | http://purl.obolibrary.org/obo/MONDO_0005502 |
| T1035 | 3963-3972 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
| T1036 | 3980-3988 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T1037 | 4123-4131 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1038 | 4123-4127 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T1039 | 4427-4431 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T101 | 247-248 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T102 | 385-393 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
| T103 | 610-611 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T104 | 664-665 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T105 | 1028-1031 | http://purl.obolibrary.org/obo/NCBITaxon_9397 | denotes | bat |
| T106 | 1113-1116 | http://purl.obolibrary.org/obo/NCBITaxon_9397 | denotes | bat |
| T107 | 1224-1225 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T108 | 1725-1730 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T109 | 1808-1809 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T110 | 2133-2134 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T111 | 2558-2563 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T112 | 2710-2713 | http://purl.obolibrary.org/obo/CLO_0001180 | denotes | 203 |
| T113 | 2716-2717 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T114 | 2728-2734 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
| T115 | 2832-2838 | http://purl.obolibrary.org/obo/NCBITaxon_9837 | denotes | camels |
| T116 | 2918-2924 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T117 | 3050-3055 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T118 | 3068-3073 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T119 | 3111-3120 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humanized |
| T120 | 3195-3200 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T121 | 3247-3252 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T122 | 3262-3266 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T123 | 3267-3276 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membranes |
| T124 | 3364-3369 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T125 | 3431-3436 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T126 | 3450-3455 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T127 | 3463-3468 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T128 | 3481-3486 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T129 | 3721-3726 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T130 | 3744-3745 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T131 | 3773-3774 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T132 | 3826-3831 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T133 | 3895-3896 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T134 | 4003-4009 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T135 | 4103-4109 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T136 | 4121-4122 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T137 | 4304-4310 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T138 | 4332-4333 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T139 | 4538-4544 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T140 | 4689-4692 | http://purl.obolibrary.org/obo/CLO_0001006 | denotes | 311 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T11445 | 285-292 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T215 | 335-342 | Chemical | denotes | epitope | http://purl.obolibrary.org/obo/CHEBI_53000 |
| T216 | 406-417 | Chemical | denotes | sialic acid | http://purl.obolibrary.org/obo/CHEBI_26667 |
| T217 | 413-417 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
| T218 | 466-473 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T219 | 801-808 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T220 | 1013-1015 | Chemical | denotes | SL | http://purl.obolibrary.org/obo/CHEBI_74815 |
| T221 | 1032-1034 | Chemical | denotes | SL | http://purl.obolibrary.org/obo/CHEBI_74815 |
| T222 | 1067-1077 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
| T223 | 1067-1072 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
| T224 | 1073-1077 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
| T225 | 1117-1119 | Chemical | denotes | SL | http://purl.obolibrary.org/obo/CHEBI_74815 |
| T226 | 1142-1152 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
| T227 | 1142-1147 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
| T228 | 1148-1152 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
| T229 | 1669-1673 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T230 | 1674-1684 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T231 | 2094-2101 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T232 | 2535-2545 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T233 | 2655-2665 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T234 | 3165-3167 | Chemical | denotes | VH | http://purl.obolibrary.org/obo/CHEBI_73700 |
| T235 | 3370-3378 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T236 | 3546-3554 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T237 | 3612-3620 | Chemical | denotes | cysteine | http://purl.obolibrary.org/obo/CHEBI_15356 |
| T238 | 4448-4461 | Chemical | denotes | antimicrobial | http://purl.obolibrary.org/obo/CHEBI_33281 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T21 | 385-400 | http://purl.obolibrary.org/obo/GO_0061025 | denotes | membrane fusion |
| T22 | 3700-3713 | http://purl.obolibrary.org/obo/GO_0006351 | denotes | transcription |
| T23 | 4545-4553 | http://purl.obolibrary.org/obo/GO_0015297 | denotes | exchange |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T770 | 0-41 | Sentence | denotes | Passive Immunization/Antibody Therapy/MAb |
| T771 | 42-144 | Sentence | denotes | Monoclonal antibodies (MAbs) may be helpful in the intervention of disease in CoV-exposed individuals. |
| T772 | 145-246 | Sentence | denotes | Patients recovering from SARS showed robust neutralizing antibodies against this CoV infection (164). |
| T773 | 247-485 | Sentence | denotes | A set of MAbs aimed at the MERS-CoV S protein-specific domains, comprising six specific epitope groups interacting with receptor-binding, membrane fusion, and sialic acid-binding sites, make up crucial entry tasks of S protein (198, 199). |
| T774 | 486-638 | Sentence | denotes | Passive immunization employing weaker and strongly neutralizing antibodies provided considerable protection in mice against a MERS-CoV lethal challenge. |
| T775 | 639-809 | Sentence | denotes | Such antibodies may play a crucial role in enhancing protective humoral responses against the emerging CoVs by aiming appropriate epitopes and functions of the S protein. |
| T776 | 810-1172 | Sentence | denotes | The cross-neutralization ability of SARS-CoV RBD-specific neutralizing MAbs considerably relies on the resemblance between their RBDs; therefore, SARS-CoV RBD-specific antibodies could cross-neutralized SL CoVs, i.e., bat-SL-CoV strain WIV1 (RBD with eight amino acid differences from SARS-CoV) but not bat-SL-CoV strain SHC014 (24 amino acid differences) (200). |
| T777 | 1173-1438 | Sentence | denotes | Appropriate RBD-specific MAbs can be recognized by a relative analysis of RBD of SARS-CoV-2 to that of SARS-CoV, and cross-neutralizing SARS-CoV RBD-specific MAbs could be explored for their effectiveness against COVID-19 and further need to be assessed clinically. |
| T778 | 1439-1551 | Sentence | denotes | The U.S. biotechnology company Regeneron is attempting to recognize potent and specific MAbs to combat COVID-19. |
| T779 | 1552-1702 | Sentence | denotes | An ideal therapeutic option suggested for SARS-CoV-2 (COVID-19) is the combination therapy comprised of MAbs and the drug remdesivir (COVID-19) (201). |
| T780 | 1703-1858 | Sentence | denotes | The SARS-CoV-specific human MAb CR3022 is found to bind with SARS-CoV-2 RBD, indicating its potential as a therapeutic agent in the management of COVID-19. |
| T781 | 1859-1994 | Sentence | denotes | It can be used alone or in combination with other effective neutralizing antibodies for the treatment and prevention of COVID-19 (202). |
| T782 | 1995-2257 | Sentence | denotes | Furthermore, SARS-CoV-specific neutralizing antibodies, like m396 and CR3014, failed to bind the S protein of SARS-CoV-2, indicating that a particular level of similarity is mandatory between the RBDs of SARS-CoV and SARS-CoV-2 for the cross-reactivity to occur. |
| T783 | 2258-2354 | Sentence | denotes | Further assessment is necessary before confirming the effectiveness of such combination therapy. |
| T784 | 2355-2504 | Sentence | denotes | In addition, to prevent further community and nosocomial spread of COVID-19, the postprocedure risk management program should not be neglected (309). |
| T785 | 2505-2715 | Sentence | denotes | Development of broad-spectrum inhibitors against the human coronaviral pathogens will help to facilitate clinical trials on the effectiveness of such inhibitors against endemic and emerging coronaviruses (203). |
| T786 | 2716-2876 | Sentence | denotes | A promising animal study revealed the protective effect of passive immunotherapy with immune serum from MERS-immune camels on mice infected with MERS-CoV (204). |
| T787 | 2877-3024 | Sentence | denotes | Passive immunotherapy using convalescent plasma is another strategy that can be used for treating COVID-19-infected, critically ill patients (205). |
| T788 | 3025-3379 | Sentence | denotes | The exploration of fully human antibodies (human single-chain antibodies; HuscFvs) or humanized nanobodies (single-domain antibodies; sdAb, VH/VHH) could aid in blocking virus replication, as these agents can traverse the virus-infected cell membranes (transbodies) and can interfere with the biological characteristics of the replicating virus proteins. |
| T789 | 3380-3493 | Sentence | denotes | Such examples include transbodies to the influenza virus, hepatitis C virus, Ebola virus, and dengue virus (206). |
| T790 | 3494-3891 | Sentence | denotes | Producing similar transbodies against intracellular proteins of coronaviruses, such as papain-like proteases (PLpro), cysteine-like protease (3CLpro), or other nsps, which are essential for replication and transcription of the virus, might formulate a practical move forward for a safer and potent passive immunization approach for virus-exposed persons and rendering therapy to infected patients. |
| T791 | 3892-4085 | Sentence | denotes | In a case study on five grimly sick patients having symptoms of severe pneumonia due to COVID-19, convalescent plasma administration was found to be helpful in patients recovering successfully. |
| T792 | 4086-4389 | Sentence | denotes | The convalescent plasma containing a SARS-CoV-2-specific ELISA (serum) antibody titer higher than 1:1,000 and neutralizing antibody titer more significant than 40 was collected from the recovered patients and used for plasma transfusion twice in a volume of 200 to 250 ml on the day of collection (310). |
| T793 | 4390-4507 | Sentence | denotes | At present, treatment for sepsis and ARDS mainly involves antimicrobial therapy, source control, and supportive care. |
| T794 | 4508-4617 | Sentence | denotes | Hence, the use of therapeutic plasma exchange can be considered an option in managing such severe conditions. |
| T795 | 4618-4694 | Sentence | denotes | Further randomized trials can be designed to investigate its efficacy (311). |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T80 | 3438-3447 | Phenotype | denotes | hepatitis | http://purl.obolibrary.org/obo/HP_0012115 |
| T81 | 3963-3972 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
| T82 | 4416-4422 | Phenotype | denotes | sepsis | http://purl.obolibrary.org/obo/HP_0100806 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3082 | 1113-1116 | Gene | denotes | bat | Gene:570 |
| 3083 | 1028-1031 | Gene | denotes | bat | Gene:570 |
| 3084 | 385-393 | Gene | denotes | membrane | Gene:43740571 |
| 3085 | 120-123 | Species | denotes | CoV | Tax:11118 |
| 3086 | 145-153 | Species | denotes | Patients | Tax:9606 |
| 3087 | 226-229 | Species | denotes | CoV | Tax:11118 |
| 3088 | 274-282 | Species | denotes | MERS-CoV | Tax:1335626 |
| 3089 | 597-601 | Species | denotes | mice | Tax:10090 |
| 3090 | 612-620 | Species | denotes | MERS-CoV | Tax:1335626 |
| 3091 | 742-746 | Species | denotes | CoVs | Tax:11118 |
| 3092 | 846-854 | Species | denotes | SARS-CoV | Tax:694009 |
| 3093 | 956-964 | Species | denotes | SARS-CoV | Tax:694009 |
| 3094 | 1016-1020 | Species | denotes | CoVs | Tax:11118 |
| 3095 | 1035-1038 | Species | denotes | CoV | Tax:11118 |
| 3096 | 1095-1103 | Species | denotes | SARS-CoV | Tax:694009 |
| 3097 | 1120-1123 | Species | denotes | CoV | Tax:11118 |
| 3098 | 406-417 | Chemical | denotes | sialic acid | MESH:D019158 |
| 3099 | 230-239 | Disease | denotes | infection | MESH:D007239 |
| 3120 | 1254-1264 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 3121 | 1276-1284 | Species | denotes | SARS-CoV | Tax:694009 |
| 3122 | 1309-1317 | Species | denotes | SARS-CoV | Tax:694009 |
| 3123 | 1594-1604 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 3124 | 1707-1715 | Species | denotes | SARS-CoV | Tax:694009 |
| 3125 | 1725-1730 | Species | denotes | human | Tax:9606 |
| 3126 | 1764-1774 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 3127 | 2008-2016 | Species | denotes | SARS-CoV | Tax:694009 |
| 3128 | 2105-2115 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 3129 | 2199-2207 | Species | denotes | SARS-CoV | Tax:694009 |
| 3130 | 2212-2222 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 3131 | 1674-1684 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 3132 | 1735-1741 | Chemical | denotes | CR3022 | |
| 3133 | 2065-2071 | Chemical | denotes | CR3014 | |
| 3134 | 1386-1394 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 3135 | 1542-1550 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 3136 | 1606-1614 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 3137 | 1686-1694 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 3138 | 1849-1857 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 3139 | 1979-1987 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 3151 | 2558-2563 | Species | denotes | human | Tax:9606 |
| 3152 | 2564-2575 | Species | denotes | coronaviral | Tax:11118 |
| 3153 | 2695-2708 | Species | denotes | coronaviruses | Tax:11118 |
| 3154 | 2832-2838 | Species | denotes | camels | Tax:9838 |
| 3155 | 2842-2846 | Species | denotes | mice | Tax:10090 |
| 3156 | 2861-2869 | Species | denotes | MERS-CoV | Tax:1335626 |
| 3157 | 3009-3017 | Species | denotes | patients | Tax:9606 |
| 3158 | 2422-2430 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 3159 | 2847-2855 | Disease | denotes | infected | MESH:D007239 |
| 3160 | 2975-2992 | Disease | denotes | COVID-19-infected | MESH:C000657245 |
| 3161 | 2994-3008 | Disease | denotes | critically ill | MESH:D016638 |
| 3174 | 3179-3182 | Gene | denotes | aid | Gene:57379 |
| 3175 | 3421-3436 | Species | denotes | influenza virus | Tax:11308 |
| 3176 | 3438-3455 | Species | denotes | hepatitis C virus | Tax:11103 |
| 3177 | 3457-3468 | Species | denotes | Ebola virus | Tax:1570291 |
| 3178 | 3474-3486 | Species | denotes | dengue virus | Tax:12637 |
| 3179 | 3558-3571 | Species | denotes | coronaviruses | Tax:11118 |
| 3180 | 3840-3847 | Species | denotes | persons | Tax:9606 |
| 3181 | 3882-3890 | Species | denotes | patients | Tax:9606 |
| 3182 | 3050-3055 | Species | denotes | human | Tax:9606 |
| 3183 | 3068-3073 | Species | denotes | human | Tax:9606 |
| 3184 | 3247-3261 | Disease | denotes | virus-infected | MESH:D001102 |
| 3185 | 3873-3881 | Disease | denotes | infected | MESH:D007239 |
| 3194 | 3928-3936 | Species | denotes | patients | Tax:9606 |
| 3195 | 4052-4060 | Species | denotes | patients | Tax:9606 |
| 3196 | 4123-4133 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 3197 | 4282-4290 | Species | denotes | patients | Tax:9606 |
| 3198 | 3963-3972 | Disease | denotes | pneumonia | MESH:D011014 |
| 3199 | 3980-3988 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 3200 | 4416-4422 | Disease | denotes | sepsis | MESH:D018805 |
| 3201 | 4427-4431 | Disease | denotes | ARDS | MESH:D012128 |